Real World Experience with Ipilimumab and Nivolumab (Ipi/Nivo) in Unresectable BRAF Wild-Type Anaplastic Thyroid Carcinoma (BRAF-WT ATC) (ATA 2026) - Sep 19, 2026 - Abstract #P641; Pres time: Nov 7, 2026; 08:30 AM - 09:30 AM; No abstract available
Clinical • Real-world • Real-world evidence • Oncology • Solid Tumor • Thyroid Gland Anaplastic Carcinoma • Thyroid Gland Carcinoma • BRAF
|
|
Sualeha Khalid; Anna Lawless; Isabelle Fournier; Anastasios Maniakas; Maria Gule-Monroe; Sarah Hamidi; Ramona Dadu; Maria Cabanillas; Mark Zafereo; Naifa Busaidy; Adam Garden; David Rosenthal; Michael Spiotto; Anna Lee; Brandon Gunn; Clifton Fuller; Stephen Ning; Victoria Banuchi; Jennifer Wang; Miriam Lango; Neal Akhave; Priyanka Iyer
|